District of Columbia, District of Columbia Clinical Trials

A listing of District of Columbia, District of Columbia clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

heart disease
lung disease
sickle cell disease
gastrointestinal symptoms
body mass index
CARE ID
 (10.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19

A Phase 2 study to evaluate the safety and preliminary efficacy of ATYR1923, compared to placebo, in hospitalized patients with SARS-CoV-2 (COVID-19) severe pneumonia not requiring mechanical ventilation

Inova Fairfax Medical Campus
 (9.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Test-Trial-29-Aug  

Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments.This study aims …

Georgetown University Medical Center Department of Neurology, 7PHC
 (1.5 away)
  • 0 views
  • 08 Sep, 2023
  • 1 location
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

dulaglutide
tirzepatide
cardiovascular disease
body mass index
MedStar Health Research Institute
 (6.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

alzheimer's disease
flortaucipir
positron emission tomography
florbetapir
mini-mental state examination
University of Pennsylvania Heath System
 (121.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +85 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

critically ill
covid-19
complete blood count
electrocardiogram
critical illness
Coronavirus Research Institute-Testing Site
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Background Glioblastoma is a type of brain cancer. Treatments include radiation, chemotherapy, and surgery. But survival rates are poor. Researchers think that the drug selinexor, when combined with chemotherapy and radiation, might help. Objective To learn the highest dose of selinexor that people with brain cancer can tolerate when given …

glioblastoma multiforme
external beam radiotherapy
therapeutic agents
selinexor
absolute neutrophil count
National Institutes of Health Clinical Center
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Background Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. No treatment specifically prevents or reduces metastasis. Researchers hope a new drug can help. It stops cancer cells from growing and spreading further and possibly shrink cancer lesions in distant …

muscle tumor
breast cancer
pediatric
primary tumor
systemic chemotherapy
National Institutes of Health Clinical Center
 (7.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Washington Institute of Dermatologic Laser Surgery
 (5.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
SPRINT Peripheral Nerve Stimulation for the Treatment of Back Pain

The purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Electrical stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) System. The SPRINT PNS …

peripheral nerve stimulation
back pain
chronic pain
electrical stimulation
low back pain
International Spine, Pain & Performance Center
 (0.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations